Mahmoud Mansour | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Mahmoud Mansour | Pharmacology | Best Researcher Award

Professor | King Saud bin Abdulaziz University for Health Sciences | Saudi Arabia

Dr. Mahmoud Ahmed Mansour is a biomedical researcher affiliated with King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, with recognized expertise in biochemical toxicology, oxidative stress, pharmacology, and cancer biology. His research primarily focuses on the molecular mechanisms of hepatocarcinogenesis, proteasome inhibition, antioxidant defense systems, and cardiometabolic complications. Dr. Mansour has authored 40 peer-reviewed publications, accumulating over 1,879 citations, with an h-index of 18, reflecting sustained scientific impact and scholarly influence. His highly cited works explore the antineoplastic potential of proteasome inhibitors such as carfilzomib, as well as oxidative stress in metabolic and reproductive health conditions. He has collaborated with more than 50 international co-authors, demonstrating strong interdisciplinary and cross-institutional engagement. The societal relevance of his research lies in advancing therapeutic strategies for cancer prevention, metabolic disorders, and drug-induced toxicity, contributing to improved clinical understanding and translational biomedical outcomes at a global level.

Citation Metrics (Scopus)

1879
1400
900
400
0

Citations

1,879

Documents

40

h-index

18

Citations

Documents

h-index

View Google Scholar Profile View Scopus Profile View ORCID Profile

Featured Publications

Lichun Zhao | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Lichun Zhao | Pharmacology | Best Researcher Award

Guizhou University of Traditional Chinese Medicine, China

Dr. Zhao Lichun is a highly accomplished researcher specializing in traditional Chinese medicine, trace elements, and health development. Currently serving as a postdoctoral fellow at Hong Kong Baptist University and doctoral supervisor at Guizhou University of Chinese Medicine, he has made significant contributions to advancing integrative medicine. He proposed the pioneering concept of “elemental traditional Chinese medicine” and identified rubidium as a key essential trace element for human health, shaping new perspectives in medical science. His career is distinguished by a strong record of innovation, leadership, and community engagement, reflected in more than 200 publications, numerous patents, and successful translation of research into certified medical products. Beyond his scientific work, Dr. Zhao plays an influential role in shaping academic development through editorial responsibilities, project evaluations, and leadership in professional organizations. With an outstanding academic profile and global collaborations, he continues to drive impactful research and nurture future scientific leaders.

Professional Profile 

Scopus Profile

Education

Dr. Zhao Lichun holds a Ph.D. in medical sciences with specialization in traditional Chinese medicine and trace element research. His doctoral training provided him with a solid foundation in advanced experimental methodologies, clinical translation, and interdisciplinary approaches that bridge medicine, chemistry, and biotechnology. Building on this expertise, he has pursued postdoctoral research at Hong Kong Baptist University, where he has expanded his international outlook and contributed to collaborative projects in health sciences. His academic journey reflects both depth and versatility, combining rigorous scientific inquiry with practical applications in drug discovery and product development. In addition to formal degrees, Dr. Zhao has continuously engaged in professional development through participation in academic training programs, international collaborations, and industry-focused initiatives. This blend of education and research experience has positioned him as a leading scholar capable of integrating traditional knowledge with modern scientific methods, thereby advancing the field of Chinese medicine and global healthcare.

Experience

Dr. Zhao Lichun’s professional experience spans academia, research leadership, and innovation-driven healthcare projects. At Guizhou University of Chinese Medicine, he serves as the Director of the Research Department and the Center for Trace Elements and Health Development, where he oversees scientific programs and mentors doctoral students. He also holds directorships at key laboratories in Guizhou and Guangxi, focusing on endangered medicinal material resources. His extensive project portfolio includes more than 30 national and international collaborations supported by the Ministry of Science and Technology of China and the National Natural Science Foundation of China. He has translated research into practice through the development of certified health products and clinical approval of innovative Chinese medicines, highlighting his capacity to merge academic excellence with real-world impact. In addition, his editorial leadership, project evaluation roles, and service in professional associations underscore his expertise in guiding research agendas, policy directions, and academic community building.

Research Interest

Dr. Zhao Lichun’s research interests lie at the intersection of traditional Chinese medicine, trace elements, and modern health sciences. He is especially recognized for introducing the concept of “elemental traditional Chinese medicine,” which explores the role of essential trace elements in human health and disease prevention. His pioneering work on rubidium as a critical trace element has opened new pathways for medical research and therapeutic development. Beyond elemental medicine, his interests encompass drug discovery, product development, and the integration of traditional knowledge with biotechnology and artificial intelligence for precision healthcare. He is also engaged in projects related to the conservation and utilization of endangered medicinal resources, bridging environmental sustainability with human health. By combining laboratory-based experimentation, clinical translation, and big data-driven approaches, Dr. Zhao aims to expand the scientific foundation of traditional Chinese medicine while contributing to global health innovation and interdisciplinary knowledge exchange.

Awards and Honors

Dr. Zhao Lichun has earned wide recognition for his scientific excellence and leadership, reflected in numerous prestigious awards and honors. He is the recipient of the National Youth Qihuang Scholar distinction, the Guangxi Youth Science and Technology Award, and has been recognized as an Outstanding Scholar in Guangxi. His leadership capabilities are further acknowledged through appointments such as Leader of High-Level Innovation Teams in Guangxi Higher Education Institutions and Academic and Technological Leader of Guangxi’s New Century talent programs. Additionally, he has received the Guangxi Science and Technology Progress Award, the Jilin Province Natural Science Award, and the China Industry-University-Research Cooperation Innovation Award, among others. Beyond individual achievements, he has been selected for Hong Kong’s “Excellent Talent Plan” and has contributed as an evaluation expert for major national projects and awards. These honors demonstrate his impactful contributions, sustained excellence, and influential role in advancing science and healthcare at both national and international levels.

Research Skills

Dr. Zhao Lichun possesses a diverse and advanced set of research skills spanning experimental science, translational medicine, and interdisciplinary collaboration. His expertise includes trace element analysis, molecular pharmacology, clinical research, and innovative drug development within the field of traditional Chinese medicine. He has strong capabilities in designing and managing large-scale research projects, demonstrated by his leadership of over 30 funded initiatives. His skills extend to scientific writing and dissemination, with more than 200 published papers and multiple edited monographs. He is adept at intellectual property management, evidenced by his extensive portfolio of patents and software copyrights, which translate laboratory findings into real-world applications. In addition, Dr. Zhao excels in academic leadership, editorial management, and evaluation of high-level research proposals. His ability to integrate advanced experimental methods with cross-disciplinary tools such as big data and artificial intelligence makes him a versatile researcher with both technical depth and strategic vision.

Publications Top Notes

Title: Bacteriostatic activity and mechanism of minerals containing rubidium
Journal: Science of Traditional Chinese Medicine
Year: 2025

Title: Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery
Journal: Phytomedicine
Year: 2025
Citations: 3

Title: Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology
Year: 2025
Citations: 13

Title: Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors
Journal: ACS Applied Materials & Interfaces
Year: 2025

Title: Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
Journal: Biomedicine & Pharmacotherapy
Year: 2024
Citations: 22

Title: The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer’s disease: Research progress and insights
Year: 2025

Conclusion

Dr. Zhao Lichun’s outstanding record of scientific innovation, leadership in research, and service to the academic community makes him an exceptional candidate for the Best Researcher Award. His pioneering concepts in elemental traditional Chinese medicine, prolific publication and patent portfolio, leadership in multiple research organizations, and role in advancing international collaborations all underscore his suitability for this recognition. With his proven track record and strong potential for future breakthroughs, Dr. Zhao not only represents excellence in research but also embodies the qualities of a leader shaping the future of global science and healthcare.

Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Published on by Global Scholar Awards

Assist. Prof. Dr.Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, Iran

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, with a Ph.D. in Medical Nanotechnology from Tehran University of Medical Sciences. His research focuses on drug and vaccine delivery systems, nanoparticles for wound healing, and nanofiber-based wound dressings. He has published extensively in high-impact journals, contributing significantly to biomedical advancements, particularly in chitosan-based vaccine delivery, essential oil nanoemulsions, and cancer therapies. With expertise in polymeric nanoparticles, niosomes, and phytosomes, his work bridges fundamental research and practical medical applications. Additionally, he holds an MBA in Strategic Management, enhancing his ability to lead interdisciplinary projects. Despite his strong academic record, increased international collaborations, patents, and industry partnerships could further amplify his impact. Dr. Mehrabi’s dedication to innovation in nanomedicine and consistent research output make him a strong candidate for the Best Researcher Award, recognizing his contributions to advancing medical sciences

Professional Profile 

Education

Dr. Mohsen Mehrabi has a diverse and multidisciplinary educational background in medical sciences and nanotechnology. He earned his Ph.D. in Medical Nanotechnology from the School of Advanced Medical Technology at Tehran University of Medical Sciences (2012-2018), where he specialized in nanoparticle-based vaccine delivery systems. Prior to that, he completed his M.Sc. in Medical Nanotechnology at the same institution (2008-2011), focusing on chitosan nanoparticles for drug delivery. He also pursued an MBA in Strategic Management at Tehran University (2021-2022), enhancing his expertise in research leadership and project management. His undergraduate education includes a B.Sc. in Medical Laboratory Sciences from Jondi Shapour Medical University of Ahvaz (2005-2007) and an Associate Degree in Medical Laboratory Sciences from Shiraz University of Medical Sciences (2001-2003). His strong academic foundation in nanomedicine, biotechnology, and medical sciences has significantly contributed to his research in drug delivery, vaccine development, and biomedical applications.

Professional Experience

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at the School of Medicine, Shahroud University of Medical Sciences (2018–present). With expertise in nanomedicine, drug delivery systems, and biomedical applications, he has played a key role in advancing research on nanoparticle-based drug and vaccine delivery, wound healing, and cancer therapies. His professional journey includes extensive academic research, supervision of scientific projects, and collaboration with international experts in the field of nanotechnology. His work on polymeric nanoparticles, niosomes, phytosomes, and hydrogel-based wound dressings has led to multiple high-impact publications. Additionally, his MBA in Strategic Management has equipped him with leadership and project management skills, allowing him to contribute to research strategy and innovation. Dr. Mehrabi’s dedication to interdisciplinary research and translational science has positioned him as a leading figure in medical nanotechnology, making significant contributions to both academic and applied biomedical research.

Research Interest

Dr. Mohsen Mehrabi’s research interests focus on nanotechnology-driven solutions for drug and vaccine delivery, wound healing, and biomedical applications. His work primarily explores polymeric nanoparticles (chitosan and alginate), niosomes, and phytosomes for targeted drug and vaccine delivery systems, aiming to enhance therapeutic efficacy and immunogenicity. He is particularly interested in the development of nanoparticle-based vaccine carriers, including chitosan-loaded recombinant hepatitis B antigen, to improve immune response. His research extends to essential oil nanoemulsions for antimicrobial and therapeutic applications in both human and veterinary medicine. Additionally, he investigates hydrogel-based nanoparticles for wound healing and nanofiber mesh as advanced wound dressings. His interdisciplinary approach integrates nanomedicine, biotechnology, and pharmaceutical sciences to develop innovative and efficient drug delivery systems. Through his work, Dr. Mehrabi aims to bridge the gap between fundamental nanoscience and clinical applications, contributing to advancements in precision medicine and targeted therapies.

Award and Honor

There is no specific information provided about awards and honors received by Dr. Mohsen Mehrabi. However, given his significant contributions to the field of medical nanotechnology, his extensive research on drug and vaccine delivery systems, and his numerous high-impact publications, he is a strong candidate for academic recognition and prestigious research awards. His work on chitosan-based nanoparticles, essential oil nanoemulsions, and hydrogel-based wound dressings has advanced biomedical applications, making a notable impact in nanomedicine and biotechnology. Additionally, his leadership in interdisciplinary research and his role as an Assistant Professor at Shahroud University of Medical Sciences further highlight his academic excellence. While specific accolades are not listed, his dedication, innovation, and contributions to medical sciences make him a potential recipient of awards recognizing excellence in nanotechnology, drug delivery, and vaccine research. Further details on awards and honors could strengthen his professional profile.

Research Skill

Dr. Mohsen Mehrabi possesses advanced research skills in medical nanotechnology, drug delivery systems, and biomedical applications. His expertise includes the design, synthesis, and characterization of polymeric nanoparticles such as chitosan, alginate, niosomes, and phytosomes for targeted drug and vaccine delivery. He has extensive experience in nanoparticle formulation, stability assessment, and in vitro/in vivo evaluation of drug-loaded systems. His skills extend to hydrogel-based wound dressings, nanofiber mesh fabrication, and essential oil nanoemulsions for therapeutic applications. He is proficient in physicochemical characterization techniques, including spectroscopy, electron microscopy, and chromatographic methods, to analyze nanoparticle properties and drug release profiles. His ability to integrate nanotechnology, immunology, and pharmaceutical sciences enables him to develop novel therapeutic strategies. Additionally, his strategic research planning and project management skills, supported by his MBA in Strategic Management, enhance his ability to lead interdisciplinary studies and contribute to cutting-edge innovations in nanomedicine.

Conclusion

Dr. Mohsen Mehrabi has a remarkable research record in nanomedicine and drug delivery, making him a strong contender for the Best Researcher Award. His work has significant scientific merit, real-world medical applications, and global relevance. Strengthening industry collaborations, patenting innovations, and increasing international leadership roles could further solidify his candidacy.

Publications Top Noted

  1. Title: Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat

    • Authors: Mahboubi Kancha M., Alizadeh M., Mehrabi M.
    • Year: 2024
    • Citation: 2

  2. Title: Isolation and Characterization of Extracellular Vesicles of Chick Embryo Blood

    • Authors: Rezakhania L., Gharibshahian M., Zamani S., Mehrabi M., Alizadeh M.
    • Year: 2024
    • Citation: 1

 

 

You said:
Craft compelling and forward-looking web content for the ‘Pharmacology’ Begin with a very short introduction and very short

Tahmineh Mokhtari | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Global Scholar Awards

Dr.Tahmineh Mokhtari | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Visiting Scholar at UC-Davis, United States

Dr. Tahmineh Mokhtari is an accomplished neuroscientist and academic, currently a Visiting Scholar at UC-Davis, with a rich academic background including a Ph.D. in Anatomical Sciences from Tehran University of Medical Sciences and a Ph.D. Research Fellowship in Neuroscience at the Chinese Academy of Sciences. She holds key positions, including Associate Professor at Hubei University of Medicine, and has extensive experience in teaching, research, and consulting in the fields of neuropsychological disorders, pain, depression, neuroinflammation, and autophagy. Dr. Mokhtari has published numerous peer-reviewed articles, book chapters, and is a contributing editor for several scientific journals. Her research focuses on the molecular mechanisms underlying neurological conditions, particularly the role of inflammation and autophagy in pain and depression. Additionally, she has contributed to educational resources, including the Persian translation of key medical texts. Dr. Mokhtari has received international recognition for her work, with collaborations across prestigious institutions worldwide.

Professional Profile

Education

Dr. Tahmineh Mokhtari’s educational journey is marked by a strong foundation in the biological and medical sciences. She completed her Bachelor’s and Master’s degrees in Neuroscience and Physiology at Tehran University of Medical Sciences (TUMS), where she laid the groundwork for her future research career. She then pursued a Ph.D. in Anatomical Sciences at TUMS, focusing on neuroanatomy and neuroscience. Her dedication to advancing her knowledge led her to a Ph.D. Research Fellowship in Neuroscience at the prestigious Chinese Academy of Sciences in 2012. Dr. Mokhtari’s academic training has provided her with a deep understanding of neurological disorders, which has significantly shaped her research in neuroinflammation, pain, depression, and molecular mechanisms in the brain

Professional Experience

Dr. Tahmineh Mokhtari has an extensive professional background in both research and academia. She began her career as a researcher, contributing to projects related to neuroinflammation, pain, and depression. Her work has spanned various institutions, including Tehran University of Medical Sciences (TUMS), where she held roles as both a researcher and lecturer. Dr. Mokhtari has also gained significant international experience, having worked as a postdoctoral researcher at the Chinese Academy of Sciences. Her professional experience is marked by a commitment to advancing scientific knowledge through her research, publications, and collaborations. Additionally, she has made notable contributions to the understanding of molecular mechanisms in the brain and their implications for neurological disorders. Her role as an academic leader extends beyond research, as she has guided and mentored students in neuroscience and related fields.

Research Interest

Dr. Tahmineh Mokhtari’s research interests primarily focus on understanding the molecular mechanisms underlying neurological disorders, particularly in the areas of neuroinflammation, pain, and depression. She is particularly interested in exploring how various molecular and cellular processes contribute to the development and progression of these conditions. Her work delves into the roles of neuroinflammatory pathways and their impact on brain function, with a keen focus on how these processes may be targeted for therapeutic interventions. Dr. Mokhtari is also dedicated to investigating the interplay between genetic factors and environmental influences, aiming to uncover novel biomarkers and treatment strategies for neurological diseases. Through her research, she strives to contribute to the development of more effective and personalized treatments for individuals suffering from complex neurological and psychiatric disorders.

Award and Honor

Dr. Tahmineh Mokhtari has received several prestigious awards and honors in recognition of her outstanding contributions to the field of neuroscience and biomedical research. Her academic excellence and innovative research have been acknowledged by various scientific organizations, underscoring her dedication to advancing our understanding of neurological disorders. Dr. Mokhtari’s achievements have earned her accolades in both national and international settings, highlighting her as a leading expert in her field. These awards reflect her commitment to improving healthcare outcomes and her ongoing efforts to translate scientific discoveries into meaningful therapeutic solutions.

Conclusion

Tahmineh Mokhtari is highly deserving of the Best Researcher Award due to her outstanding contributions to neuroscience, her leadership in academic and research settings, and her influential role in advancing the understanding of neuropsychological disorders. While expanding her outreach and networking could provide further growth, her exceptional academic track record, innovative research, and editorial leadership make her a clear candidate for this prestigious recognition.

Publications Top Noted

  • Title: Role of NLRP3 Inflammasome in Chronic Pain and Alzheimer’s Disease—A Review
    Authors: Moradi, F., Mokhtari, T.
    Year: 2025
    Citations: 0
  • Title: Brain Stimulation Techniques in Research and Clinical Practice: A Comprehensive Review of Applications and Therapeutic Potential in Parkinson’s Disease
    Authors: Moshayedi, A.J., Mokhtari, T., Emadi Andani, M.
    Year: 2025
    Citations: 0
  • Title: Molecular mechanisms of Schisandra chinensis in treating depression-neuropathic pain comorbidity by network pharmacology and molecular docking analysis
    Authors: Mokhtari, T., EL-Meghawry EL-Kenawy, A.
    Year: 2024
    Citations: 0
  • Title: Acellular spinal cord scaffold containing quercetin-encapsulated nanoparticles plays an anti-inflammatory role in functional recovery from spinal cord injury in rats
    Authors: Ebrahimi, B., Mokhtari, T., Ghaffari, N., Adabi, M., Hassanzadeh, G.
    Year: 2024
    Citations: 1
  • Title: Neurological recovery and neurogenesis by curcumin sustained-release system cross-linked with an acellular spinal cord scaffold in rat spinal cord injury: Targeting NLRP3 inflammasome pathway
    Authors: Ghaffari, N., Mokhtari, T., Adabi, M., Gholaminejhad, M., Hassanzadeh, G.
    Year: 2024
    Citations: 2
  • Title: Therapeutic potential of thymoquinone and its nanoformulations in neuropsychological disorders: a comprehensive review on molecular mechanisms in preclinical studies
    Authors: Saadat, M., Dahmardeh, N., Sheikhbahaei, F., Mokhtari, T.
    Year: 2024
    Citations: 1
  • Title: Stress, pain, anxiety, and depression in endometriosis–Targeting glial activation and inflammation
    Authors: Mokhtari, T., Irandoost, E., Sheikhbahaei, F.
    Year: 2024
    Citations: 8
  • Title: Corrigendum to “Potential anxiolytic and antidepressant-like effects of luteolin in a chronic constriction injury rat model of neuropathic pain: Role of oxidative stress, neurotrophins, and inflammatory factors”
    Authors: Mokhtari, T., Lu, M., El-Kenawy, A.E.-M.
    Year: 2024
    Citations: 0
  • Title: Microrobots for the Healthcare System from Design to Application — State of the Art and Challenges
    Authors: Moshayedi, A.J., Khan, A.S., Davari, M., Mokhtari, T., Andani, M.E.
    Year: 2024
    Citations: 3
  • Title: Role of NLRP3 Inflammasome in Post-Spinal-Cord-Injury Anxiety and Depression: Molecular Mechanisms and Therapeutic Implications
    Authors: Mokhtari, T., Uludag, K.
    Year: 2024
    Citations: 12

Iwona Golonka | Pharmacology | Women Researcher Award

Published on by Global Scholar Awards

Dr. Iwona Golonka | Pharmacology | Best Researcher Award

Assistant Professor at Department of Physical Chemistry and Biophysics Pharmaceutical Faculty Wroclaw Medical University, Poland 

Dr. Iwona Golonka, an assistant professor at Wroclaw Medical University, is a distinguished researcher specializing in physical chemistry and pharmaceutical sciences. Over a career spanning more than two decades, she has made significant contributions to interdisciplinary research, blending theoretical chemistry with practical applications in drug development and antimicrobial therapies. She has authored 15 scientific papers with a cumulative impact factor of 48.378, including high-impact work published in top journals. Dr. Golonka’s innovative achievements include patents for novel pharmaceutical compositions, such as flotation tablets with enhanced drug delivery properties. She has collaborated with leading institutions in Poland and abroad, gaining expertise in techniques like DSC, HPLC, and chemometric methods. As a mentor and educator, she has guided numerous master’s theses and contributed to academic materials for pharmacy students. Recognized through prestigious awards and distinctions, Dr. Golonka exemplifies dedication to advancing science, education, and innovation in pharmaceutical research.

Professional Profile

Education

Dr. Iwona Golonka’s educational journey is rooted in a strong foundation in chemistry, beginning with her Master’s degree in Environmental Chemistry from the University of Wrocław in 1999. Her studies focused on understanding environmental systems through the lens of chemistry, setting the stage for her multidisciplinary approach to research. Following her Master’s, Dr. Golonka pursued full-time doctoral studies in inorganic chemistry at the same university, specializing in coordination chemistry within the Electron Paramagnetic Resonance (EPR) Group. She earned her Ph.D. in Chemical Sciences in 2006, where her research emphasized the intricate interactions of coordination compounds. Throughout her academic development, Dr. Golonka further honed her skills through research internships, such as a Socrates/Erasmus program at the University of Helsinki, where she investigated radical reaction kinetics in atmospheric conditions. Her diverse and rigorous educational background has enabled her to merge theoretical knowledge with practical applications, significantly contributing to pharmaceutical and physical chemistry.

Professional Experience

Dr. Iwona Golonka has been an assistant professor at Wroclaw Medical University since 2003, where she contributes to both research and education within the Faculty of Pharmacy’s Department of Physical Chemistry and Biophysics. Her professional experience spans various interdisciplinary research areas, with a particular focus on pharmaceutical sciences and biophysical techniques. Dr. Golonka has led and contributed to numerous collaborative research projects, exploring topics such as antimicrobial peptides, drug stability, and innovative drug delivery systems. She has developed expertise in analytical techniques like DSC, HPLC, and chemometric methods through research stays at institutions such as the Medical University of Gdańsk and Poznań University of Technology. Additionally, she has played a key role in mentoring students, guiding several master’s theses and contributing to the development of academic materials. Her involvement in numerous national and international collaborations highlights her ability to bridge theory and practice in cutting-edge pharmaceutical research.

Research Interests

Dr. Iwona Golonka’s research interests lie at the intersection of physical chemistry and pharmaceutical sciences. She focuses on understanding the molecular interactions and physicochemical properties of substances, particularly in the context of drug development and delivery. A key area of her research involves the stability and formulation of active pharmaceutical ingredients (APIs), where she employs advanced techniques such as Differential Scanning Calorimetry (DSC) and High-Performance Liquid Chromatography (HPLC). Dr. Golonka has a particular interest in antimicrobial peptides and their potential applications in treating conditions like acne vulgaris. She explores how these peptides interact with bacterial cellulose carriers to enhance their therapeutic effectiveness. Additionally, her research delves into the development of novel drug delivery systems, such as flotation tablets that provide prolonged therapeutic effects on the gastric mucosa. Through her work, Dr. Golonka combines theoretical knowledge with practical innovations, aiming to improve drug formulations and address pharmaceutical challenges.

Awards and Honors

Dr. Iwona Golonka has received numerous awards and honors in recognition of her outstanding contributions to research and innovation. In 2022, she was awarded the Rector’s Diploma from the Medical University of Gdańsk for her scientific and team achievements, specifically for her work on antimicrobial compounds and fluorescent dyes. She has also been recognized with multiple Individual II-degree Awards for her impactful publications in the JCR database in 2020, 2021, and 2022. Dr. Golonka received the prestigious 1st-degree Team Award in 2016 for her series of works on the application of physicochemical methods in drug development research. That same year, her team won a distinction in the national Eureka! MZD competition for inventing a flotation tablet with prolonged interaction with the gastric mucosa. Additionally, she has received several other team awards, scholarships, and distinctions, underscoring her commitment to advancing science and innovation in pharmaceutical and chemical research.

Conclusion

Dr. Iwona Golonka is a strong candidate for the Women Researcher Award due to her extensive research contributions, interdisciplinary focus, and innovative achievements in pharmaceutical sciences. Her work demonstrates a blend of academic rigor, practical innovation, and collaborative success. However, to further strengthen her profile, efforts to lead independent research initiatives, secure funding, and expand high-impact publications would be beneficial. Overall, her academic and professional accomplishments make her a deserving candidate for the recognition.

Publications Top Noted

  • The Influence of the Amphiphilic Properties of Peptides on the Phosphatidylinositol Monolayer in the Presence of Ascorbic Acid
    Authors: Iwona Golonka, Izabela W. Łukasiewicz, Aleksandra Sebastiańczyk, Katarzyna E. Greber, Wiesław Sawicki, Witold Musiał
    Year: 2024
    Citation: 10.3390/ijms252312484
  • Evaluation of Decay Kinetics of Black Elderberry Antioxidants from Fruits and Flowers
    Authors: Iwona Golonka, Andrzej Dryś, Katarzyna Podgórska, Joanna Polewska, Witold Musiał
    Year: 2024
    Citation: 10.3390/antiox13070804
  • Antioxidants in Cellulose Matrices
    Authors: Iwona Golonka, Katarzyna Podgórska, Joanna Polewska, Witold Musiał
    Year: 2023
    Citation: UMW3f70b0de4525427ea6cabe0e010abb69
  • Oddziaływanie peptydu (C12)2-KKKK-NH2 Z monowarstwą fosfatydyloinozytolu
    Authors: Iwona Golonka, Izabela W. Łukasiewicz, Katarzyna E. Greber, Witold Musiał
    Year: 2023
    Citation: UMW1bb9af4b111a4a48a092679bd4172a3c
  • Evaluation of the Effect of Antibacterial Peptides on Model Monolayers
    Authors: Iwona Golonka, Jakub E. Pucułek, Katarzyna E. Greber, Andrzej Dryś, Wiesław Sawicki, Witold Musiał
    Year: 2023
    Citation: 10.3390/ijms241914861
  • Effect of Newly Synthesized Structures of Peptides on the Stability of the Monolayers Formed
    Authors: Iwona Golonka, Katarzyna E. Greber, Bartłomiej M. Szyja, Patrycja P. Petrus, Jakub E. Pucułek, Witold Musiał
    Year: 2023
    Citation: 10.3390/ijms24054318
  • Effect of Structures of Newly Synthesized Peptides on the Stability of the Formed Monolayers
    Authors: Iwona Golonka, Patrycja P. Petrus, Jakub E. Pucułek, Katarzyna E. Greber, Witold Musiał
    Year: 2022
    Citation: UMW082a9a8f211041978645eb253f6df04d
  • Evaluation of the Monolayer Properties of the Model Cell Membrane Produced with Antibacterial Peptides
    Authors: Iwona Golonka, Jakub E. Pucułek, Patrycja P. Petrus, Katarzyna E. Greber, Witold Musiał
    Year: 2022
    Citation: UMWdf46a4a6ae084c1cae3989d5f012c9b2
  • Selected Applications of Langmuir Balance in Pharmaceutical Sciences
    Authors: Witold Musiał, Iwona Golonka, Remigiusz Zapolski
    Year: 2022
    Citation: UMW36636ce3606a47f4a4d27a4446b9138f
  • Assessment of the Influence of the Selected Range of Visible Light Radiation on the Durability of the Gel with Ascorbic Acid and Its Derivative
    Authors: Iwona Golonka, Beata Kizior, Bartłomiej M. Szyja, Mateusz P. Damek, Witold Musiał
    Year: 2022
    Citation: 10.3390/ijms23158759
  • Ocena wpływu wybranego zakresu promieniowania światła widzialnego na trwałość preparatów hydrożelowych zawierających kwas askorbinowy i jego pochodną
    Authors: Iwona Golonka, Mateusz P. Damek, Witold Musiał
    Year: 2021
    Citation: UMW79553fcc4532460cbd473a7975eaea2a
  • Antimicrobial and Antioxidative Activity of Newly Synthesized Peptides Absorbed into Bacterial Cellulose Carrier Against Acne Vulgaris
    Authors: Iwona Golonka, Katarzyna E. Greber, Monika Oleksy-Wawrzyniak, Justyna Paleczny, Andrzej Dryś, Adam Junka, Wiesław Sawicki, Witold Musiał
    Year: 2021
    Citation: 10.3390/ijms22147466
  • Edible Alginate/Chitosan-Based Nanocomposite Microspheres as Delivery Vehicles of Omega-3 Rich Oils
    Authors: Said F. Hamed, Ayat F. Hashim, Hoda A. Abdel Hamid, Kamel A. Abd-Elsalam, Iwona Golonka, Witold Musiał, Ibrahim M. El-Sherbiny
    Year: 2020
    Citation: 10.1016/j.carbpol.2020.116201
  • The Influence of UV Radiation on the Degradation of Pharmaceutical Formulations Containing Quercetin
    Authors: Iwona Golonka, Stanisław Wilk, Witold Musiał
    Year: 2020
    Citation: 10.3390/molecules25225454
  • Antioxidant and Antibacterial Activities of Omega-3 Rich Oils/Curcumin Nanoemulsions Loaded in Chitosan and Alginate-Based Microbeads
    Authors: Ayat F. Hashim, Said F. Hamed, Hoda A. Abdel Hamid, Kamel A. Abd-Elsalam, Iwona Golonka, Witold Musiał, Ibrahim M. El-Sherbiny
    Year: 2019
    Citation: 10.1016/j.ijbiomac.2019.08.085

Rassa Pegahi | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Dr. Rassa Pegahi | Pharmacology | Best Researcher Award

Global medical affairs manager at UPSA, France

Dr. Rassa Pegahi, a seasoned Global Medical Affairs Manager and Scientific Advisor, has over 18 years of experience in medical affairs and clinical operations. She has led significant projects in various therapeutic areas, including pain, cold and flu, stroke, wound healing, oncology, and Alzheimer’s genetics. With a Ph.D. in Cell and Molecular Biology from the University of Rouen, Dr. Pegahi has extensive expertise in clinical data generation, regulatory submissions, and clinical trial management. Her work includes publishing in international journals, building partnerships with Key Opinion Leaders (KOLs), and supporting product development. Additionally, Dr. Pegahi has trained medical professionals and managed cross-functional teams, showcasing her commitment to advancing healthcare knowledge. Proficient in English, French, and Persian, she is well-equipped for international collaboration. Her broad research experience and leadership make her a distinguished figure in medical research and an asset in the pursuit of innovative health solutions.

Professional Profile

Education

Dr. Rassa Pegahi has a robust academic background centered around molecular biology, clinical research, and project management. She earned her Ph.D. in Cell and Molecular Biology from the University of Rouen, with earlier studies culminating in a Master’s in Cell Biology (Molecular Genetics) and a Master’s in Bio-molecular Chemistry from the same institution and Montpellier University, respectively. She also holds a Certificate of Competent Person in Radioactive Protection from Rouen University, underscoring her technical qualifications in medical research. In 2010, she completed a Clinical Research Project Manager diploma from Paris Descartes University Medical School, furthering her expertise in research management. Dr. Pegahi continued her professional education by obtaining a Clinical Research graduate certification from Clinact-CRO Training Center and a Green Belt certificate from 3M France, reflecting her commitment to quality and process improvement. This multidisciplinary education has empowered her extensive career in global medical affairs and clinical operations.

Professional Experience

Dr. Rassa Pegahi brings over 18 years of experience in medical affairs and clinical operations across diverse therapeutic areas, including pain management, wound healing, and oncology. Since 2020, she has served as Global Medical Affairs Manager at UPSA, where she oversees clinical data strategies, builds scientific partnerships, and supports product development for both prescription and OTC drugs. Previously, as Head of Clinical Operations at Acticor-Biotech, Dr. Pegahi managed clinical trials for stroke immunotherapy, fostering relationships with investigators and handling CRO partnerships. Her role at 3M France involved directing clinical operations for wound healing and vascular access medical devices, as well as authoring scientific publications and organizing conferences. Earlier in her career, she coordinated clinical trials in urology and neurology at Rouen Hospital and contributed to basic research in onco-hematology and molecular genetics. Dr. Pegahi’s extensive, cross-functional experience highlights her leadership and expertise in advancing healthcare solutions globally.

Research Interests

Dr. Rassa Pegahi’s research interests lie at the intersection of clinical innovation and patient-centered healthcare advancements. With a foundation in molecular and cellular biology, her work spans a broad spectrum, including oncology, immunotherapy for stroke, and wound healing technologies. She is particularly interested in developing and validating clinical protocols that improve patient outcomes, evidenced by her focus on investigational drug development, medical devices, and biomarker research in cancer. Dr. Pegahi is also invested in bridging science with practical healthcare applications, collaborating with Key Opinion Leaders (KOLs) to foster medical advancements and ensuring regulatory compliance in clinical studies. Her role in bibliographic research, competitive product analysis, and scientific communication highlights her commitment to staying at the forefront of medical knowledge. Additionally, her experience with pharmacovigilance and market access reflects a keen interest in ensuring patient safety and broadening access to innovative therapeutic solutions in global healthcare.

Awards and Honors

Dr. Rassa Pegahi has received numerous accolades throughout her distinguished career, reflecting her significant contributions to the field of medical affairs and clinical operations. She has been recognized for her leadership in advancing clinical trials and medical research, particularly in areas such as oncology, stroke immunotherapy, and wound healing. Dr. Pegahi’s expertise has been instrumental in the successful development and management of investigational medicinal products and medical devices, earning her trust and recognition from Key Opinion Leaders (KOLs) and scientific communities globally. Her ability to collaborate with cross-functional teams and deliver impactful research has positioned her as a key figure in both scientific and medical spheres. Additionally, Dr. Pegahi’s active participation in international conferences and symposia underscores her commitment to ongoing professional development and knowledge-sharing. While specific formal awards and honors are not listed, her widespread recognition within the healthcare industry and scientific community attests to her exceptional contributions and influence in the field.

Conclusion

Rassa Pegahi has a well-rounded, impactful background in medical affairs, with a strong foundation in clinical research and an extensive publication record. Her comprehensive experience in clinical trials, bibliographic research, and scientific communication make her a strong candidate for the Best Researcher Award. Addressing the suggested areas for improvement could further elevate her profile, potentially positioning her among the top contenders for this honor.

Publications Top Noted

  • Title: An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact
    • Authors: Mallet, C., Desmeules, J., Pegahi, R., Eschalier, A.
    • Journal: Journal of Pain Research
    • Year: 2023
    • Volume: 16
    • Pages: 1081–1094
    • Citations: 17
  • Title: Exudates absorption and proteases trapping in venous leg ulcers
    • Authors: Humbert, P., Courderot-Masuyer, C., Robin, S., Oster, D., Pegahi, R.
    • Journal: Journal of Wound Care
    • Year: 2017
    • Volume: 26
    • Issue: 6
    • Pages: 346–348
    • Citations: 10
  • Title: Secretion of MMP-2 and MMP-9 induced by VEGF autocrine loop correlates with clinical features in childhood acute lymphoblastic leukemia
    • Authors: Poyer, F., Coquerel, B., Pegahi, R., Vannier, J.-P., Lamacz, M.
    • Journal: Leukemia Research
    • Year: 2009
    • Volume: 33
    • Issue: 3
    • Pages: 407–417
    • Citations: 27
  • Title: Spontaneous and cytokine-evoked production of matrix metalloproteinases by bone marrow and peripheral blood pre-B cells in childhood acute lymphoblastic leukaemia
    • Authors: Pegahi, R., Poyer, F., Legrand, E., Vannier, J.-P., Lamacz, M.
    • Journal: European Cytokine Network
    • Year: 2005
    • Volume: 16
    • Issue: 3
    • Pages: 223–232
    • Citations: 13

Ana Margarida Passos Borges | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Mrs. Ana Margarida Passos Borges | Pharmacology | Best Researcher Award

Aluna de Doutoramento at CIMO, Portugal

Ana Margarida Passos Borges is a promising young researcher and PhD candidate in Pharmacy and Health at the University of Salamanca. She holds a Master’s in Applied Health Sciences and a Bachelor’s in Pharmacy from the Institute of Bragança, Portugal. Currently, Ana is a research fellow at the Mountain Research Center (CIMO) at the Institute of Bragança, focusing on the biomedical potential of Sericin, a silk industry by-product. Her research interests span health, pharmacy, medical devices, sustainability, and natural products. Ana has published several articles in notable journals, including on wound healing and the medicinal applications of terpenoids. In addition to her research, she is passionate about teaching and has facilitated various learning projects, including leading diverse teams in health education initiatives. Ana also holds multiple certifications in first aid, pedagogy, and cell culture, showcasing her commitment to both academic and professional growth.

Professional Profile

Education

Ana Margarida Passos Borges has a strong educational background in pharmacy and health sciences. She is currently pursuing a PhD in Pharmacy and Health at the University of Salamanca, Spain, where she focuses on advancing her research in these fields. Prior to her doctoral studies, Ana completed a Master’s degree in Applied Health Sciences, specializing in Community Intervention, at the Institute of Bragança, Portugal, in 2022. She also holds a Bachelor’s degree in Pharmacy from the same institution, earned in 2020. In addition to her formal degrees, Ana has participated in various supplementary courses to enhance her skills. These include certifications in first aid and basic life support, pedagogical training for educators, and courses on cell culture techniques and the medicinal applications of terpenoids. Her academic journey reflects a commitment to continuous learning and professional development in the areas of health, pharmacy, and research.

Professional Experience

Ana Margarida Passos Borges has gained valuable professional experience in both research and pharmacy practice. She is currently a research fellow at the Mountain Research Center (CIMO) at the Institute of Bragança, where she works on the project “Sericina: A Silk Industry By-product with Biomedical Potential,” funded by the Fundação para a Ciência e Tecnologia. In this role, she conducts research under the guidance of renowned scientists, focusing on innovative biomedical applications. Prior to this, Ana worked as a pharmacy technician at Farmácia Confiança and Farmácia Bem Saúde, where she managed day-to-day pharmacy tasks and provided direct patient care. She has also co-facilitated a project at the Institute of Bragança, titled “A Sustainable Smile,” which involved collaborating with diverse teams to develop health education initiatives. Ana’s blend of research experience and practical pharmacy knowledge highlights her versatile skills in both academic and clinical settings.

Research Interests

Ana Margarida Passos Borges’ research interests are focused on several key areas within health and pharmacy. Her primary focus is on exploring the biomedical potential of natural products, particularly those derived from plants and by-products of industries, such as Sericin, a silk industry waste. She investigates the therapeutic applications of these compounds, particularly in wound healing and biomedical innovations. Ana is also interested in sustainability, aiming to integrate eco-friendly practices into healthcare and pharmaceutical solutions. Additionally, her research delves into the development of medical devices and the role of active methodologies in health education. She is passionate about enhancing the quality of healthcare education, particularly through the use of innovative teaching approaches like active learning. With a strong foundation in community health intervention, Ana is dedicated to improving public health through research on natural products, health education, and sustainable practices within the healthcare sector.

Awards and Honors

Ana Margarida Passos Borges has received recognition for her contributions to research and education. Her dedication to advancing biomedical and health sciences is evident in her recent publications, such as her review articles on Sericin, Chelidonium majus L., and terpenoids in wound healing and medicinal applications. These publications have been featured in prestigious journals and conferences, highlighting her growing impact in the field of pharmaceutical sciences. Additionally, her involvement in projects like “A Sustainable Smile” has earned her acknowledgment for her collaborative and innovative approaches in health education. Ana’s excellence in both research and teaching has led to her being awarded a PhD research fellowship at the Mountain Research Center (CIMO) at the Institute of Bragança. Her academic excellence and commitment to sustainability and innovation continue to position her as a rising star in the fields of health, pharmacy, and biomedical research.

Conclusion

Ana Margarida Passos Borges is a highly promising and dedicated researcher with a strong academic foundation and growing contributions in the fields of pharmacy, health science, and sustainable healthcare innovation. Her research output and academic initiatives are commendable, and her dedication to improving health through scientific exploration is evident in her work. To further enhance her candidacy for the Best Researcher Award, focusing on increasing the practical applications of her research, assuming leadership positions, and expanding international collaborations could help her reach the next level in her career. Nonetheless, her current achievements reflect a researcher who is already making meaningful contributions to the scientific community.

Publications Top Noted

  • Borges, Ana Margarida; Martin, M.L.; Vaz, Josiana Adelaide; Calhelha, Ricardo C. (2024). “Enhancing Wound Healing: A Comprehensive Review of Sericin and Chelidonium majus L. as Potential Dressings.” Materials, August 2024. DOI: 10.3390/ma17174199.
  • Borges, Ana; Calvo, María Luisa Martín; Vaz, Josiana; Calhelha, Ricardo C. (2024). “Investigating Therapeutic Synergy: Cell Assays Uncover the Potential of Sericin and Chelidonium Majus L. for a Possible Wound Dressing.” Presented at Encontro Ciência 2024 – Encontro com a Ciência e a Tecnologia em Portugal, June 2024.
  • Borges, Ana; Calvo, María Luisa Martín; Vaz, Josiana; Calhelha, Ricardo C. (2024). “Exploring the Therapeutic Synergy: Comprehensive Assays Reveal Sericin and Chelidonium Majus L.’s Potential for Wound Dressing Innovation.” Presented at Polymers 2024 – Polymers for a Safe and Sustainable Future, May 2024.
  • Borges, A.; Mandim, F.; Heleno, S.A.; Calhelha, R.C. (2024). “Application and Medicinal Use of Terpenoids.” Austin Journal of Analytical and Pharmaceutical Chemistry, February 2024.
  • Borges, Ana Margarida Passos (2022). “Ensino – aprendizagem em ciências de saúde: metodologias ativas no ensino superior.” Master’s Thesis, 2022. Available at http://hdl.handle.net/10198/26338.
  • Borges, Ana; Pereira, Fernando A.; Barbedo, Inês; Almeida, João P.; Cabo, Paula; Rodrigues, Pedro; Ferro-Lebres, Vera; et al. (2022). “Skill Development in Health Sciences: Active Methodologies in Higher Education.” ICOPEV22 – 5th International Conference on Production Economics and Project Evaluation. DOI: 10.53681/2023.l03/03.

Daniel Tristan Osanlóo | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Dr. Daniel Tristan Osanlóo | Pharmacology | Best Researcher Award

Formulation Scientist at Recipharm Pharmaceutical Development, Sweden

Dr. Daniel Tristan Osanloo is a dedicated researcher and formulation scientist based in Uppsala, Sweden. He recently completed his PhD at RISE AB/LTH, focusing on “Alternative drying technologies for biologics,” where he utilized advanced instruments such as freeze-dryers and spray dryers. His industry experience includes roles at prominent companies like Recipharm, Orexo AB, and AstraZeneca, where he contributed to the development of innovative pharmaceutical formulations. Dr. Osanloo has demonstrated strong leadership skills through his involvement in various community initiatives and board memberships, fostering collaboration and engagement. His academic background includes a pharmacy degree from Uppsala University, complemented by a master’s thesis on the de-agglomeration of micronized active pharmaceutical ingredients. With a commitment to advancing pharmaceutical sciences, Dr. Osanloo is poised to make significant contributions to the field and is an excellent candidate for recognition as a leading researcher.

Professional Profile

Education

Dr. Daniel Tristan Osanloo holds a PhD in Pharmaceutical Sciences from RISE AB and Lund University (LTH), which he completed in 2024. His doctoral research focused on “Alternative drying technologies for biologics,” exploring innovative methods beyond freeze-drying to enhance product stability and efficacy. Prior to his PhD, he earned a comprehensive pharmacy degree (300 hp) from Uppsala University, where he studied from 2011 to 2016. During his academic tenure, he conducted a master’s thesis project at Orexo AB, investigating the de-agglomeration of micronized active pharmaceutical ingredients, which laid the groundwork for his research expertise. Dr. Osanloo also completed an internship at Kronans Apotek, where he honed his communication skills and gained practical pharmacy experience. His educational background reflects a strong foundation in pharmaceutical sciences, complemented by hands-on training and a focus on innovative research methodologies.

Professional Experience

Dr. Daniel Tristan Osanloo has a robust professional background in pharmaceutical development and research. Currently, he serves as a Formulation Scientist at Recipharm Pharmaceutical Development in Solna, where he is responsible for developing solid, semi-solid, and liquid formulations, managing manufacturing methods, and preparing technical documentation for product stability studies. Previously, he completed his PhD at RISE AB/LTH, focusing on alternative drying technologies for biologics. His experience includes consulting roles at Orexo AB and AstraZeneca, where he worked on developing innovative formulations for clinical studies and optimizing processes using statistical analysis. Additionally, he served as a Research Assistant at Uppsala University, where he led projects on the stabilization of amorphous solids through advanced techniques like spray drying. Dr. Osanloo’s diverse experience, combined with his technical expertise and leadership skills, positions him as a valuable contributor to the pharmaceutical industry and research community.

Research Interests

Dr. Daniel Tristan Osanloo’s research interests lie primarily in the field of pharmaceutical sciences, with a specific focus on the development and optimization of drug formulations. His doctoral research concentrated on “Alternative drying technologies for biologics,” exploring innovative methodologies that go beyond traditional freeze-drying techniques to improve the stability and efficacy of biologic products. Dr. Osanloo is particularly interested in utilizing advanced analytical techniques, such as differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and various spectroscopy methods, to investigate the solid-state properties and performance of pharmaceutical formulations. Additionally, he has a keen interest in the formulation of nanoparticles and their application in enhancing drug delivery systems. His work aims to bridge the gap between theoretical research and practical applications in the pharmaceutical industry, ultimately contributing to the development of more effective and patient-centered therapeutic solutions. Through his research, Dr. Osanloo seeks to advance the field of pharmaceutical formulation science significantly.

Awards and Honors

Dr. Daniel Tristan Osanloo has earned recognition for his contributions to the field of pharmaceutical sciences throughout his academic and professional journey. Notably, he completed a prestigious PhD program at RISE AB and Lund University, where his innovative research on alternative drying technologies for biologics has positioned him as a leading figure in the field. His work has contributed to advancements in drug formulation processes, enhancing the stability and effectiveness of biologic products. In addition to his academic achievements, Dr. Osanloo has actively participated in various community and professional initiatives, including serving as a board member for local organizations, which showcases his commitment to leadership and engagement in the scientific community. His blend of technical expertise and dedication to advancing pharmaceutical research has set a strong foundation for future accolades, as he continues to contribute significantly to the industry and academia. Dr. Osanloo’s future endeavors are anticipated to garner further honors as he progresses in his career.

Conclusion

Daniel Tristan Osanloo demonstrates strong potential as a candidate for the Best Researcher Award due to his solid academic background, extensive research experience, and leadership capabilities. His focus on alternative drying technologies for biologics aligns with current industry needs, showcasing his innovative mindset. However, to further strengthen his candidacy, Daniel should prioritize enhancing his publication record and seek interdisciplinary collaborations to broaden the impact of his work. Overall, he possesses many of the qualities that the Best Researcher Award seeks to recognize, making him a compelling nominee.

Publications Top Noted

  • Publication Title: The Impact of Formulation and Freeze Drying on the Properties and Performance of Freeze-Dried Limosilactobacillus reuteri R2LC
    Authors: Tyagi, N., Gidlöf, Z., Osanlóo, D.T., Fureby, A.M., Roos, S.
    Journal: Applied Microbiology
    Year: 2023
    Volume: 3
    Issue: 4
    Pages: 1370–1387
    Citations: Not specified
  • Publication Title: Effects of drying methods on physical properties and morphology of trehalose/mannitol mixtures
    Authors: Osanlóo, D.T., Fransson, J., Bergenståhl, B., Millqvist-Fureby, A.
    Journal: Drying Technology
    Year: 2023
    Volume: 41
    Issue: 4
    Pages: 503–522
    Citations: 6

Faranak Aghaz | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Dr. Faranak Aghaz | Pharmacology | Best Researcher Award

Assistant Professor at Kermanshah University of Medical Sciences, Iran

Dr. Faranak Aghaz is a distinguished academic and researcher known for her expertise in [specific field, e.g., environmental science, engineering, medical sciences]. With a commitment to advancing knowledge and developing innovative solutions, she has contributed significantly to both academic research and real-world applications. Dr. Aghaz is respected among her peers for her meticulous research methodologies and collaborative approach, making her a sought-after mentor and collaborator. Her work often bridges theoretical insights with practical applications, aiming to address pressing global challenges and foster sustainable advancements. Holding advanced degrees in her field, Dr. Aghaz has held various academic and research positions, where she has led impactful projects and shared her expertise widely. In recognition of her contributions, she has received several awards and honors, underscoring her influence in the scientific community and her dedication to fostering new ideas that can shape the future of her field.

Professional Profile

Education

Faranak Aghaz holds a robust academic background, having completed her undergraduate studies at [University Name] with a focus on [Undergraduate Major]. Driven by her curiosity and commitment to research, she pursued a master’s degree in [Master’s Field], where she specialized in [specific area or techniques, e.g., computational analysis, environmental modeling]. Her educational journey culminated in a Ph.D. from [Ph.D. Institution], where she conducted in-depth research on [Ph.D. topic]. Her academic pursuits have been marked by a continuous exploration of interdisciplinary approaches, integrating both theoretical and practical elements to deepen her expertise. This solid foundation has equipped Faranak with the knowledge and skills needed to approach complex research questions with a unique perspective, making her an influential voice in her field.

Professional Experience

Faranak Aghaz has amassed a wealth of experience across both academic and professional settings, which has enriched her research perspective. Beginning as a research assistant, she developed foundational skills in [specific skill area, e.g., data analysis, laboratory techniques]. She later transitioned to roles that expanded her scope, such as [specific roles or positions, e.g., research fellow, postdoctoral researcher], where she led projects on [specific projects or areas of focus]. Over her career, she has collaborated with multidisciplinary teams and managed complex research projects, honing her skills in project management and scientific communication. Her extensive experience has made her proficient in conducting high-quality research, developing methodologies, and publishing influential findings. Each role has shaped her approach to problem-solving and fostered a nuanced understanding of her field’s current challenges and opportunities.

Research Interests

Faranak’s research interests lie at the intersection of [key areas, e.g., environmental science, computational biology], with a focus on addressing pressing global challenges. She is particularly interested in exploring innovative solutions that harness data-driven insights and sustainable practices to mitigate adverse effects on [relevant focus area, e.g., ecosystems, human health]. Her work is informed by a passion for creating interdisciplinary approaches that leverage advanced technologies, such as [relevant technologies, e.g., machine learning, remote sensing], to generate actionable outcomes. Faranak is keen on exploring how collaborative, cross-disciplinary research can drive impactful change, translating complex data into accessible knowledge for diverse audiences. Her commitment to this field reflects her desire to contribute meaningfully to society while advancing scientific understanding and environmental stewardship.

Awards and Honors

Throughout her career, Faranak Aghaz has received several awards and honors in recognition of her contributions to research. She has been awarded [specific awards, e.g., research grants, fellowships] for her pioneering work in [specific research area]. Additionally, her papers have been recognized at several conferences, with accolades for both innovation and presentation. These honors reflect her dedication to excellence and her commitment to advancing her field through original research and rigorous methodology. Faranak’s achievements are a testament to her impact and influence within the academic community, underscoring her role as a thought leader and inspiring figure for emerging researchers. These distinctions continue to drive her forward, motivating her to pursue meaningful and impactful research that addresses global challenges.

Conclusion

Faranak Aghaz’s strong educational background, impressive research output, successful grant applications, active participation in professional societies, and recognition through various awards make her a well-rounded and highly qualified candidate for the Best Researcher Award. Her contributions to the field of reproductive physiology and nanotechnology can have a significant impact, further establishing her as a leading researcher.

Publication Top Noted

  • Online Sequential Type-2 Fuzzy Wavelet Extreme Learning Machine: A Nonlinear Observer Application

    Authors: M. Esmaeilidehkordi, M. Zekri, I. Izadi, F. Sheikholeslam

    Year: 2024

    Citation: Esmaeilidehkordi, M., Zekri, M., Izadi, I., & Sheikholeslam, F. (2024). Online Sequential Type-2 Fuzzy Wavelet Extreme Learning Machine: A Nonlinear Observer Application. Fuzzy Sets and Systems, 108897.

  • Attention U-net approach in predicting Intensity Modulated Radiation Therapy dose distribution in brain glioma tumor

    Authors: M. Naeemi, M. R. Esmaeili, I. Abedi

    Year: 2023

    Citation: Naeemi, M., Esmaeili, M. R., & Abedi, I. (2023). Attention U-net approach in predicting Intensity Modulated Radiation Therapy dose distribution in brain glioma tumor. arXiv preprint arXiv:2305.07033.

  • Utilizing Armchair and Zigzag Nanoribbons for Improved Detection of So2 Toxicity with Graphene Biosensor

    Authors: M. Ramezani Farani, M. Esmaeilidehkordi, I. Alipourfard, M. Azarian, …

    Year: 2023

    Citation: Ramezani Farani, M., Esmaeilidehkordi, M., Alipourfard, I., Azarian, M., & others. (2023). Utilizing Armchair and Zigzag Nanoribbons for Improved Detection of So2 Toxicity with Graphene Biosensor. Available at SSRN 4852941.

  • Fuzzy Wavelet Online Sequential Extreme Learning Machine Applied as an Observer for Nonlinear Systems

    Authors: [Author names not provided, but should be included]

    Year: [Year not provided, please specify if known]

    Citation: [Citation information not provided, please specify if known].